Pharmaceuticals News

SEATTLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...

Previously announced wind-down of the legacy cell therapy activities is substantially complete  Mechelen, Belgium; October 14, 2026, 22.01 CEST; Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

De eerder aangekondigde afbouw van de voormalige celtherapieactiviteiten is nagenoeg afgerond Mechelen, België; 14 oktober 2026, 22. 01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

If approved, tinlarebant would be the first-ever approved treatment for Stargardt Disease Type 1 in Singapore, United Kingdom, and SwitzerlandAccess pathway submission combined with accepted new drug...

The National Stem Cell Foundation (NSCF), Axiom Space, and the Saudi Space Agency today announced a collaboration that launched aboard SpaceX CRS-35 to the

Siren Biotechnology Appoints Former FDA CBER Oncology Branch Chief to Clinical and Scientific Advisory Board

Lyon (France), October 14, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in meetings with...

Lyon (France), le 14 octobre 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que des membres de son équipe dirigeante feront des...

Combination achieved mOS of 23.8 months in patients with unresectable or metastatic HCC FORT LEE, N.J., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of...

Neion Bio and Barnwell Bio partner to bring metagenomic biosurveillance to Neion’s egg-based biologics manufacturing flocks as it scales Raptor.